COVID-19 accelerates the progression of atherosclerotic plaques, increasing coronary inflammation and the risk of high-risk ...

20 U.S. states (plus D.C.) had "very high" levels of SARS-CoV-2—the virus that causes COVID-19—present in wastewater for the week between December 29, 2024 and January 04, 2025. This is a jump ...

Paxlovid vs placebo reduced COVID-19-related hospitalization and death due to any cause through 28 days, as well as the duration of COVID-19 symptoms.

An imbalance in gene activity in two types of immune cells explains why lung fibrosis after a severe COVID-19 infection doesn ...

Overall respiratory illness activity-- including flu, COVID-19 and RSV -- continues to be listed as "high" nationwide and is causing people to seek health care "at a high level," according to the ...

In sum, the findings illustrate fluoxetine's weak antiviral activity in adults with early symptomatic COVID-19. There were no significant differences in the time to symptom or fever resolution ...

Seventeen states around the U.S. reported "very high" wastewater levels of SARS-CoV-2—the virus that causes COVID-19—during the week between January 5 and January 11. This is a drop from the ...